Academia.eduAcademia.edu

Outline

<title>Fluctuations and noise in cancer development</title>

2004, Noise in Complex Systems and Stochastic Dynamics II

https://doi.org/10.1117/12.546641

Abstract

This paper explores fluctuations and noise in various facets of cancer development. The three areas of particular focus are the stochastic progression of cells to cancer, fluctuations of the tumor size during treatment, and noise in cancer cell signalling. We explore the stochastic dynamics of tumor growth and response to treatment using a Markov model, and fluctutions in tumor size in response to treatment using partial differential equations. We also explore noise within gene networks in cancer cells, and noise in inter-cell signalling.

References (25)

  1. S. Ginzburg and M. A. Pustovit, "Bursting dynamics of a model neuron induced by intrinsic channel noise," Fluctuation and Noise Letters 3, pp. L265-L274, Sept. 2003.
  2. A. V. Belyakov, L. K. J. Vandamme, M. Y. Perov, and A. V. Yakimov, "The different physical origins of 1/f noise and superimposed rts noise in light-emitting quantum dot diodes," Fluctuation and Noise Letters 3, pp. L325-L339, Sept. 2003.
  3. L. Telesca, V. Cuomo, V. Lapenna, and M. Macchiato, "1/f α fluctuations of seismic sequences," Fluctu- ations and Noise Letters 2, pp. L357-L367, Dec. 2002.
  4. B. Davis, "Numerical methods for systems excited by white noise," in Unsolved Problems of Noise and Fluctuations: 2nd International Conference, D. Abbott and L. B. Kish, eds., 511, pp. 533-538, AIP, July 1999.
  5. T. L. Jackson and H. M. Byrne, "A mathematical model to study the effects of drug resistance and vasculature on the response of solid tumors to chemotherapy," Mathematical Biosciences 164, pp. 17-38, 2000.
  6. E. M. J. Boon, J. J. Keller, T. A. M. Wormhoudt, F. M. Giardello, G. J. A. Offerhaus, R. van der Neut, and S. T. Pals, "Sulindac targets nuclear β-catenin accumulation and Wnt signalling in adenomas of patients with familial adenomatous polyposis and in human colorectal cancer cell lines," British Journal of Cancer 90, pp. 224-229, 2004.
  7. A. L. Jackson and L. A. Loeb, "The mutation rate and cancer," Genetics 148, pp. 1483-1490, 1998.
  8. D. P. Cahill, K. W. Kinzler, B. Vogelstein, and C. Lengauer, "Genetic instability and darwinian selection in tumours," Trends Cell Biology 9, pp. M57-M60, 1999.
  9. J. B. Plotkin and M. A. Nowak, "The different effects of apoptosis and DNA repair on tumorigenesis," Journal of Theoretical Biology 214, pp. 453-467, 2002.
  10. D. Hanahan and R. Weinberg, "The hallmarks of cancer," Cell 100, pp. 57-70, 2000.
  11. E. G. Luebeck and S. H. Moolgavkar, "Multistage carcinogenesis and the incidence of colorectal cancer," PNAS 99, pp. 15095-15100, 2002.
  12. J. Folkman, "What is the evidence that tumors are angiogenesis dependent?," Journal of the National Cancer Institute 82, pp. 4-6, 1990.
  13. S. Friberg and S. Mattson, "On the growth rates of human malignant tumors: Implications for medical decision making," Journal of Surgical Oncology 65, pp. 284-297, 1997.
  14. D. A. Rew and G. D. Wilson, "Cell production rates in human tissues and tumours and their significance. Part II: clinical data.," European Journal of Surgical Oncology 26, pp. 405-417, 2000.
  15. I. P. M. Tomlinson and W. F. Bodmer, "Failure of programmed cell death and differentiation as causes of tumors: some simple mathematical models," PNAS 92, pp. 11130-11134, 1995.
  16. F. H. Igney and P. H. Krammer, "Death and anti-death: tumor resistance to apoptosis," Nature Reviews Cancer 2, pp. 277-288, 2002.
  17. B. Vogelstein, D. Lane, and A. J. Levine, "Surfing the p53 network," Nature 408, pp. 307-310, 2000.
  18. T. L. Jackson, S. R. Lubkin, and J. D. Murray, "Theoretical analysis of conjugate localization in two-step cancer chemotherapy," Journal of Mathematical Biology 39, pp. 353-376, 1999.
  19. D. E. Kerr, G. J. Schreiber, V. M. Vrudhula, H. P. Svensson, I. Hellstron, K. E. Hellstrom, and P. D. Senter, "Regressions and cures of melanoma xenografts following treatment with monoclonal antibody β-lactamase conjugates in combination with anticancer prodrugs," Cancer Research 55, pp. 3558-3563, 1995.
  20. P. Polakis, "Wnt signaling and cancer," Genes and Development 14, pp. 1837-1851, Aug. 2000.
  21. A. M. C. Brown, "Wnt signaling in breast cancer: have we come full circle?," Breast Cancer Research 3, pp. 351-355, Sept. 2001.
  22. E. Lee, A. Salic, R. Krüger, R. Heinrich, and M. W. Kirschner, "The roles of APC and axin derived from experimental and theoretical analysis of the Wnt pathway," PLoS Biology 1, pp. 116-132, Oct. 2003.
  23. H. Aberle, A. Bauer, J. Stappert, A. Kispert, and R. Kemler, "β-catenin is a target for the ubiquitin- proteasome pathway," The EMBO Journal 16, pp. 3797-3804, July 1997.
  24. F. M. Giardiello, S. R. Hamilton, A. J. Krush, S. Piantadosi, L. M. Hylind, P. Celano, S. V. Booker, C. R. Robinson, and G. J. Offerhaus, "Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis," New England Journal of Medicine 328, pp. 1313-1316, 1993.
  25. Y. Mansury and T. Deisboeck, "Simulating 'structure-function' patterns of malignant brain tumors," Physica A 331, pp. 219-232, 2004.